545 related articles for article (PubMed ID: 15254333)
21. Local lymph node assay: validation assessment for regulatory purposes.
Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
[TBL] [Abstract][Full Text] [Related]
22. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
23. Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-κB signaling and are less sensitizing than S(N)Ar- and S(N)2- reactive chemicals.
Natsch A; Haupt T; Laue H
Chem Res Toxicol; 2011 Nov; 24(11):2018-27. PubMed ID: 22023385
[TBL] [Abstract][Full Text] [Related]
24. The direct peptide reactivity assay: selectivity of chemical respiratory allergens.
Lalko JF; Kimber I; Gerberick GF; Foertsch LM; Api AM; Dearman RJ
Toxicol Sci; 2012 Oct; 129(2):421-31. PubMed ID: 22713598
[TBL] [Abstract][Full Text] [Related]
25. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
26. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing.
Natsch A; Emter R; Ellis G
Toxicol Sci; 2009 Jan; 107(1):106-21. PubMed ID: 18832184
[TBL] [Abstract][Full Text] [Related]
27. Peptide reactivity assay using spectrophotometric method for high-throughput screening of skin sensitization potential of chemical haptens.
Jeong YH; An S; Shin K; Lee TR
Toxicol In Vitro; 2013 Feb; 27(1):264-71. PubMed ID: 22981993
[TBL] [Abstract][Full Text] [Related]
28. Allergic contact dermatitis--formation, structural requirements, and reactivity of skin sensitizers.
Karlberg AT; Bergström MA; Börje A; Luthman K; Nilsson JL
Chem Res Toxicol; 2008 Jan; 21(1):53-69. PubMed ID: 18052130
[TBL] [Abstract][Full Text] [Related]
29. The local lymph node assay and the assessment of relative potency: status of validation.
Basketter DA; Gerberick F; Kimber I
Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
[TBL] [Abstract][Full Text] [Related]
30. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system.
Gerberick GF; Troutman JA; Foertsch LM; Vassallo JD; Quijano M; Dobson RL; Goebel C; Lepoittevin JP
Toxicol Sci; 2009 Nov; 112(1):164-74. PubMed ID: 19748994
[TBL] [Abstract][Full Text] [Related]
31. Chemical basis for the extreme skin sensitization potency of (E)-4-(ethoxymethylene)-2-phenyloxazol-5(4H)-one.
Natsch A; Gfeller H; Kuhn F; Granier T; Roberts DW
Chem Res Toxicol; 2010 Dec; 23(12):1913-20. PubMed ID: 20866106
[TBL] [Abstract][Full Text] [Related]
32. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.
Basketter DA; Gerberick GF; Kimber I
Cutan Ocul Toxicol; 2007; 26(4):293-301. PubMed ID: 18058304
[TBL] [Abstract][Full Text] [Related]
33. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
[TBL] [Abstract][Full Text] [Related]
34. The reduced local lymph node assay: the impact of group size.
Ryan CA; Chaney JG; Kern PS; Patlewicz GY; Basketter DA; Betts CJ; Dearman RJ; Kimber I; Gerberick GF
J Appl Toxicol; 2008 May; 28(4):518-23. PubMed ID: 17879259
[TBL] [Abstract][Full Text] [Related]
35. Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro.
Natsch A; Gfeller H; Rothaupt M; Ellis G
Toxicol In Vitro; 2007 Oct; 21(7):1220-6. PubMed ID: 17513083
[TBL] [Abstract][Full Text] [Related]
36. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
Gerberick GF; Cruse LW; Ryan CA
Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
[TBL] [Abstract][Full Text] [Related]
37. Validity of methods to predict the respiratory sensitizing potential of chemicals: A study with a piperidinyl chlorotriazine derivative that caused an outbreak of occupational asthma.
Vanoirbeek JA; Mandervelt C; Cunningham AR; Hoet PH; Xu H; Vanhooren HM; Nemery B
Toxicol Sci; 2003 Dec; 76(2):338-46. PubMed ID: 14514965
[TBL] [Abstract][Full Text] [Related]
38. In vitro approaches to the identification and characterization of skin sensitizers.
Basketter D; Maxwell G
Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
[TBL] [Abstract][Full Text] [Related]
39. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
[TBL] [Abstract][Full Text] [Related]
40. Metabolic epoxidation of an alpha,beta-unsaturated oxime generates sensitizers of extreme potency. Are nitroso intermediates responsible?
Bergström MA; Luthman K; Karlberg AT
Chem Res Toxicol; 2007 Jun; 20(6):927-36. PubMed ID: 17511479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
